Analyst firms · Barclays · GDRX

Barclays GDRX price target and rating history

GoodRx Holdings Inc. (GDRX) · Technology

Barclays rates GoodRx Holdings Inc. (GDRX) Underweight with a $3 price target, as of its latest action on Dec 9, 2025. It has published 5 rating actions on GDRX since August 2021, including 1 upgrade and 0 downgrades.

Current rating

Underweight

Price target

$3

Median target, all firms

Too few

Actions on GDRX

5

Barclays price target on GDRX

Every Barclays rating on GDRX

• Dec 9, 2025
  InitiateBarclays starts coverage at Underweight, price target $3
• Mar 8, 2022
  ReiterateBarclays cuts its price target to $28 from $35, keeps Overweight
• Mar 1, 2022
  ReiterateBarclays cuts its price target to $35 from $43, keeps Overweight
• Nov 11, 2021
  ReiterateBarclays raises its price target to $47 from $45, keeps Overweight
• Aug 31, 2021
  UpgradeBarclays upgrades to Overweight from Equal Weight, price target $45

How other firms rate GDRX

Each firm's latest rating and stated target in the last 12 months.

Questions about Barclays and GDRX

What is Barclays's price target for GDRX?

Barclays's latest stated price target for GoodRx Holdings Inc. (GDRX) is $3, from its action on Dec 9, 2025.

What is Barclays's rating on GDRX?

Barclays rates GDRX Underweight, a bearish rating, as of Dec 9, 2025.

When did Barclays last change its view on GDRX?

On Dec 9, 2025, Barclays starts coverage at Underweight, price target $3.

More GDRX rating histories

• Raymond James6
• RBC Capital Markets3
• J.P. Morgan3
• Leerink Partners4
• BofA Securities3
• TD Cowen3
• Goldman Sachs3
• Credit Suisse3
• Morgan Stanley3

All Barclays ratingsGDRX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.